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ABSTRACT 
Objectives. To establish reference curves of the Australian/Canadian Hand Osteoarthritis Index 
(AUSCAN), a widely used questionnaire assessing hand complaints. 
Methods. Analyses were performed in a population-based sample, the Netherlands Epidemiology of 
Obesity study (n=6,671, aged 45-65 years). Factors associated with AUSCAN scores were analysed 
with ordered logistic regression, since AUSCAN data were zero-inflated, dividing AUSCAN into three 
categories (0 vs. 1-5 vs. >5). Age- and sex-specific reference curves for the AUSCAN (range 0-60, 
higher is worse) were developed using quantile regression in conjunction with fractional 
polynomials. Observed scores in relevant subgroups were compared to the reference curves. 
Results. Median age was 56 (interquartile range (IQR) 50-61), 56% were women and 12% had hand 
osteoarthritis according to American College of Rheumatology criteria. AUSCAN scores were low 
(median 1, IQR 0-4). Reference curves where higher for women, and moderately increased with age: 
95% percentiles for AUSCAN in men and women were respectively 5.0 and 12.3 points for a 45-year-
old, and 15.2 and 33.6 points for a 65-year-old individual. Additional associated factors included 
hand osteoarthritis, inflammatory rheumatic diseases, fibromyalgia, socio-economic status, and BMI. 
Median AUSCAN pain subscale scores of women with hand osteoarthritis lay between the 75th and 
90th centiles of the general population.  
Conclusions. AUSCAN scores in the middle-aged Dutch population were overall low and higher in 
women than in men. AUSCAN reference curves could serve as benchmark in research and clinical 
practice settings. However, the AUSCAN does not measure hand complaints specific for hand 
osteoarthritis. 
 
Keywords: Hand osteoarthritis, outcomes research, epidemiology 
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KEY MESSAGES 
- Australian/Canadian Hand Osteoarthritis Index age- and sex-specific reference curves in a 
middle-aged population are presented. 
- Presented Australian/Canadian Hand Osteoarthritis Index reference curves could serve as 
benchmark in research and clinical practice.  
 
 
INTRODUCTION 
Hand complaints are frequent in the general population[1]. Hand osteoarthritis (OA) is a common 
cause of hand complaints such as pain and functional disability[2]. Current treatment strategies for 
hand OA aim to alleviate symptoms, although their efficacy is limited[3]. Clinical trials aiming for 
disease modification have been conducted recently, or are still on-going[3]. 
Assessment of patient-reported outcomes is important to evaluate treatment. The 
Australian/Canadian Hand Osteoarthritis Index (AUSCAN) is a widely used instrument, recognised by 
both Osteoarthritis Research Society International (OARSI) and Outcome Measures in Rheumatology 
Clinical Trials (OMERACT) as a valid and reliable outcome in clinical trials for hand OA[4-6]. The 
interpretation of patient-reported outcomes like the AUSCAN however, depends on the availability 
of benchmarks, such as the patient acceptable symptom state (PASS). Recently, a PASS for the 
AUSCAN was established in a multinational sample of patients with OA[7]. A disadvantage of the 
PASS is that it is a cut-off value, which is not adjusted for age and sex. Population-based normative 
values can also serve as benchmarks. Previously, age- and sex-specific normative values for the 
AUSCAN were developed in an Australian population-based cohort[8]. Limitations of this study, 
however, were the limited availability of information on other characteristics of the studied 
population, and the definition of normative values solely based on descriptive analysis of observed 
scores. 
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The objective of this study was to investigate factors associated with AUSCAN scores in the middle-
aged Dutch population, such as sex, body mass index (BMI), socio-economic status (SES), and 
presence of hand OA or other (inflammatory) rheumatic diseases, and to establish reference curves 
for the AUSCAN taking associated factors in account. 
 
METHODS 
Study design and study population 
The Netherlands Epidemiology of Obesity (NEO) study is a population-based cohort. Detailed 
information about study design and data collection are described elsewhere[9]. Men and women 
aged between 45 and 65 years with a self-reported BMI ≥27 kg/m2 living in the greater area of 
Leiden (The Netherlands) were eligible to participate, resulting in 5,000 participants. Additionally, all 
inhabitants aged between 45 and 65 years from one municipality (Leiderdorp) were invited, 
irrespective of their BMI, resulting in 1,671 additional participants, and allowing a reference 
distribution of BMI. The present study is a cross-sectional analysis of baseline measurements of the 
NEO study. The study was approved by the medical ethics committee of the Leiden University 
Medical Center (LUMC) and all participants gave written informed consent. 
 
Data collection 
All participants completed questionnaires on demographic and clinical data and visited the study 
centre for baseline measurements including physical examination. 
Questionnaires included standardised questions on ethnicity (self-identification in eight categories, 
which we grouped into white (reference) and other), education (the highest form of education from 
which the participant had graduated, which we grouped into poorly (none, primary school or lower 
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vocational education; reference) versus highly educated), income (monthly net personal income, 
divided into seven categories ranging from less than €500 to more than €3,000), the presence of 
self-reported rheumatic diseases (i.e., rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), 
gout, fibromyalgia, psoriatic arthritis, and ankylosing spondylitis), and self-reported hand pain and 
stiffness on most days of the prior month (present or absent). The AUSCAN was completed on a 5-
point Likert scale, with a total score ranging from 0 to 60, and scores from the three subscales pain, 
stiffness and function ranging from 0 to 20, 4 and 36 respectively (higher scores are worse). Physical 
examination of the hands was performed by trained research nurses, assessing bony and soft 
swellings, deformities and pain on palpation in the distal interphalangeal (DIP), proximal 
interphalangeal (PIP), metacarpophalangeal, and first carpometacarpal (CMC-1) joints. Primary hand 
OA was defined as fulfilment of the American College of Rheumatology criteria for hand OA, without 
a concurrent inflammatory rheumatic disease (RA, SLE, gout, psoriatic arthritis or ankylosing 
spondylitis)[10]. “Pre-hand OA” was defined as having hand pain, and at least two bony swellings or 
deformities in the DIP, PIP, or CMC-1 joints, without being classified as having primary hand OA or 
reporting an inflammatory rheumatic disease. 
 
Statistical analyses 
In the NEO study there is an oversampling of persons with a BMI ≥27 kg/m2. To correctly represent 
distributions and associations in the general population[11], adjustments for the oversampling of 
individuals with a BMI ≥27 kg/m2 were made. This was done by weighting individuals towards the 
BMI distribution of participants from the Leiderdorp municipality[12], whose BMI distribution was 
similar to that of the general Dutch population[13]. All results were based on weighted analyses, 
using probability weights in Stata. Consequently, results apply to a population-based study without 
oversampling. 
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Ordered logistic regression analyses were performed to examine factors associated with increasing 
AUSCAN scores. For this purpose, three categories of AUSCAN total (0 versus 1-5 versus >5) and each 
subscale (0 versus 1-2 versus >2 for pain and function, and 0 versus 1 versus >1 for stiffness) were 
created. Cut-offs for AUSCAN categories were chosen in a way that the upper two categories were 
approximately equal in size, and that the cut-off values of the subscales added up to the cut-off 
value of the total score. Ordered logistic regression was chosen, because AUSCAN data were heavily 
zero-inflated (reflecting absence of hand complaints in most individuals). Participants with missing 
data of all AUSCAN subscales or physical examination were excluded from these analyses. Analyses 
were stratified by sex. Associations were expressed as odds ratios (ORs) with 95% confidence 
intervals (CIs), representing the OR of being in the highest compared to the middle or lowest 
AUSCAN category for a unit change in the determinant. 
Age- and sex-specific reference curves were developed for the AUSCAN total and its subscales, 
except the stiffness subscale, because it is a single question. The curves were developed similar to 
the approach used for development of short form-36 population norms and children’s growth 
curves, using data from all participants, i.e. not excluding those with hand complaints. We applied a 
commonly used method to derive reference curves, based on fractional polynomials described by 
Royston and Wright[14]. Since a parametric approach was not possible in our zero-inflated data, 
reference curves were derived using quantile regression in conjunction with fractional polynomials. 
This allows quantiles to be estimated as a smooth function of covariates without imposing 
parametric distributional assumptions, allowing to construct reference curves on data that do not 
meet the assumptions of normality, linearity, and constant variance[15 16]. The application of 
fractional polynomials provides the possibility to account for a curved relationship between the 
independent (i.e., age) and the dependent variable (i.e., AUSCAN score). The 75th, 90th, 95th, 97.5th 
and 99th centiles were derived. Powers for the fractional polynomial models were taken from a 
predefined set (S = {-2, -1, -0.5, 0, 0.5, 1, 2, 3}). Simple functions were preferred; more complicated 
functions were accepted only if the fit was substantially improved. Adjustments for other covariates 
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assessed in the regression analyses were only made if deemed necessary, to improve feasibility in 
practical application. The goodness of fit of the regression line of the simple function was inspected 
visually first. If it was judged that the line did not fit the data well, fit of the regression line of the 
more complicated function was visually inspected and the deviance of both models was compared 
(estimated as nobs*log(∑adev  / ∑rdev), where nobs is the number of observations, ∑adev  is the sum of 
absolute deviations and ∑rdev is the sum of raw deviations). Only when the fit of the more 
complicated model was both visually and statistically significantly better (p<0.05), was the complex 
model adapted. The final percentile curves were compared with observed (unweighted) values of 
the AUSCAN in subgroups hypothesised to have high AUSCAN scores (e.g., individuals with primary 
hand OA). 
Items from the questionnaire driving high scores were explored. Therefore, in the subgroup of 
participants with high pain or function subscale scores, defined as a score >2 for that subscale, 
histograms of the proportion of participants that scored positive on each item were made, as well as 
histograms of the proportion of participants with each possible score (0, 1, 2, 3 or 4) on each item. 
An item was flagged as a driver of high scores when the proportion of participants with a positive 
score on that item was higher, or the distribution of the participants’ scores within that item was 
more skewed towards high scores than on the other items. 
Data were analysed using Stata V14, StataCorp LP, Texas. 
 
RESULTS 
Population characteristics 
After exclusion of individuals with missing data on all AUSCAN subscales (n=14) and physical 
examination (n=14), data from 6,643 participants were analysed. Table 1 shows the participants’ 
characteristics. Median age was 56 years (interquartile range (IQR) 50 to 61), and 56% were women. 
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Primary hand OA was present in 6% of men and 16% of women, and its prevalence increased with 
increasing age (2.4% in individuals aged 44 to 48 year, up to 16.3% in the age group 61 to 66). 
Median AUSCAN scores were low in both men and women, although scores were higher in women 
and increased slightly with age (median (IQR) 0 (0-2) in the age group 44-48 years, up to 1 (0-6.4) in 
the age group 61-66). However, even in the highest age category, AUSCAN scores remained low. 
 
Associations with AUSCAN scores 
We assessed associations of factors that were hypothesised to be related with AUSCAN scores in 
men and women with univariable followed by multivariable ordered logistic regression analyses 
(Table 2). Regression analyses in the three subscales of the AUSCAN yielded similar results (not 
shown). Associated factors were age, presence of primary hand OA, presence of self-reported 
inflammatory rheumatic diseases or fibromyalgia, “pre-hand OA”, education (as proxy for SES), and 
BMI. These associations were similar in men and women, although after correction for rheumatic 
diseases, BMI in men and education in women were no longer associated with AUSCAN.  
 
Reference curves 
Age- and sex-specific AUSCAN reference curves and associated percentiles are presented in Figures 
1A-F and Table 3. No additional covariates were deemed essential to be taken into account for 
development of the curves. Most curves were derived using the simplest fractional polynomial 
function (i.e., a first degree fractional polynomial, introducing only one power in the function of the 
regression line), except the 99th percentile of the AUSCAN pain subscale in men, which was fitted 
with a second degree fractional polynomial (introducing two powers in the function of the 
regression line). The function of the regression line for each percentile, an estimation example and a 
table with regression coefficients are published as online supplementary files (Supplementary text 1 
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and Table S1). Reference curves for women were generally higher than those for men. For instance, 
the 95% percentiles for AUSCAN in men were 5.0 and 15.2 points for a 45- and a 65-year-old 
respectively, whereas for women these were 12.3 and 33.6 points. Although AUSCAN scores 
moderately increased with age in both sexes, maximum scores were not reached and the score 
plateaued at 40.  
 
Subgroup specific AUSCAN scores relative to reference curves 
In Figure 2A and 2B reference curves of AUSCAN pain are plotted over boxplots of observed AUSCAN 
scores of women with primary hand OA and self-reported fibromyalgia respectively. The median 
AUSCAN pain score of women with primary hand OA lay between the 75th and 90th percentile curves 
of the general population. Scores of women with self-reported fibromyalgia were even higher 
(between the 90th and 95th percentiles). Moreover, AUSCAN pain scores of women with primary 
hand OA did not seem to increase markedly with age. A similar figure of women with inflammatory 
rheumatic diseases showed comparable results as the figure with primary hand OA (not shown).  
 
Items driving high AUSCAN scores 
In participants with a high pain subscale (>2), especially the items assessing pain during activities 
(grabbing, lifting, turning and squeezing objects) were scored positive by many (88-96%). For the 
function subscale the most important items appraised difficulty with opening jars and grabbing large 
or heavy objects (94% and 83% scored these items positive), and to a lesser extent difficulty in 
carrying objects with one hand and squeezing a cloth (62% and 63% with positive score). Results for 
men and women were similar (not shown). 
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DISCUSSION 
In this study we developed age- and sex-specific reference curves for the AUSCAN in the middle-
aged Dutch population. Overall, AUSCAN scores were low, and women reported more hand 
complaints than men. This gender difference is in part explained by a higher prevalence of hand OA 
in women. Besides, it is possible that women report hand complaints more readily than men do[17]. 
Furthermore, many participants had a score of zero, and the percentile curves plateaued at a score 
of 40 on the AUSCAN total. This might indicate that there is a lack of items assessing mild symptoms 
or relatively easy tasks. We saw that mainly squeezing and turning motions led to pain and 
functional limitation, and perhaps other items only depart from normal in extreme situations (e.g., 
end-stage disease of hand OA). 
Previously described normative values in an Australian population-based sample also showed 
increasing hand complaints with increasing age and similar differences between men and women[8]. 
However, AUSCAN scores reported in that cohort did not clearly plateau and were overall higher 
than what we observed. This may be explained by cultural differences, as previous studies have 
highlighted important differences across countries in the assessment of patient-reported 
outcomes[18], or the occurrence of selection bias in the Australian study (i.e., individuals with more 
complaints might have been more inclined to return the mailed questionnaire). A different 
percentage of participants with hand OA or other rheumatic diseases could also explain the 
discrepancies, but this information is not available for the Australian cohort. Moreover, the authors 
applied different statistical analyses, using empirical centiles based on descriptive analysis to define 
normative values for different age categories. Empirical centiles can be biased in small samples, and 
estimates are known to be inefficient and have large variance[19]. Reference curves for outcome 
measures are preferably developed using regression models, adjusting for important factors (e.g., 
age), as has been done for the well-known and extensively used growth curves[14 20].  
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An important limitation of our study is the age range of included participants, limiting the age range 
for which reference curves could be developed. However, the included age range is the most 
relevant, since it is the timeframe in which the prevalence of symptomatic as well as radiological 
hand OA steeply increases and as a consequence it can be expected that the prevalence of hand 
complaints increases too[21 22]. Besides, we used self-reported data on other rheumatic diseases 
than hand OA, without validating these in medical records, although a recent review suggested that 
the accuracy of self-reported RA is acceptable for large-scale studies[23]. Furthermore, the low 
prevalence of rheumatic diseases sometimes led to excessively large ORs and corresponding CIs, 
such as for fibromyalgia, resulting in an inaccurate estimate of the true size of the association 
between AUSCAN and these diseases. Finally, a disadvantage of the AUSCAN is that it is not freely 
available (copyrighted), but nevertheless it was used for this study since it is the most widely used 
hand-specific questionnaire with evidence of good metric properties[24]. 
An important strength of the NEO study is its large sample size and the availability of extensive 
demographic and clinical data with few missing data. Another strength of our study was the solid 
methodology used for the statistical analysis, based on the methodology used for the development 
of pediatric growth curves by the World Health Organization[20]. Since a parametric approach was 
not possible, we adopted a modified approach (i.e., quantile regression in conjunction with 
fractional polynomials). A similar method was used previously to develop reference curves for 
radiographic damage in RA patients[16]. Quantile regression is robust and flexible, and an important 
advantage is that it allows age to remain a continuous variable[25]. The latter enables the 
computation of a value for the reference curve for every year of age, and it makes the charts easier 
to use, because the x-axis is in years rather than in age categories. A drawback, however, is that this 
approach lacks an explicit formula to convert measurements into quantiles and z-scores, and that 
the produced curves may be irregular near the extremes[25].  
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These reference curves can serve as a useful benchmark in hand OA in both research and clinical 
practice settings. By plotting the AUSCAN score of an individual on the chart, their measurement can 
be expressed as a centile. These charts can be used to compare AUSCAN scores across different 
populations (see figure 2), compare scores of the same population at different occasions, or to 
detect aberrant individual scores[26]. It is also possible to plot a sequence of measurements over 
time of an individual in the same chart. A person whose ‘individual curve’ tracks along the same 
centile over time, develops hand complaints expected according to their increase in age. Yet if their 
‘individual curve’ ‘crosses’ centiles up or down, that person may develop complaints faster or slower 
than average. One has to be cautious with the latter interpretation, however, since our analyses 
were performed cross-sectionally and therefore do not contain information on the variability 
between individuals in the increase in AUSCAN over time[26]. Cross-sectional curves that are 
interpreted in a longitudinal manner (i.e., following an individual over time), can especially be 
misleading when the rate of change is high, for example growth during infancy or puberty, because a 
mean cross-sectional curve partly smooths out this peak growth[27]. However, the increase of 
AUSCAN over time is only moderate and it is unlikely that variations between individuals in slope of 
AUSCAN over time are pronounced. Therefore, we believe that these reference curves can also be 
applied in the follow-up of individuals over time, as long as results are interpreted with caution.  
The strong associations of AUSCAN with many other factors besides primary hand OA underline that 
this instrument does not measure hand OA specific complaints. This should be kept in mind when 
using the AUSCAN. AUSCAN pain scores of individuals with self-reported fibromyalgia were even 
higher than those of participants with primary hand OA. Since we also know that fibromyalgia-like 
symptoms are prevalent in hand OA patients, this finding stresses the difficulties and complexity in 
recognizing the origin of complaints in hand OA patients[28]. Furthermore, our study provides more 
evidence that the burden of disease in patients with hand OA is at least similar to that of RA 
patients, since both subgroups had equally high AUSCAN scores[29]. 
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FIGURE LEGENDS 
Figure 1. Age- and sex-specific reference curves for AUSCAN total, AUSCAN pain and AUSCAN 
function in men (A, C, E) and women (B, D, F). 
 
Figure 2. Reference curves for AUSCAN pain plotted over boxplots of the observed (unweighted) 
values of the AUSCAN scores of women with primary hand OA (A) and self-reported fibromyalgia (B). 
Each box represents the IQR, with the median represented by a horizontal line within the box. 
Whiskers represent the smallest and largest value within 1.5 IQR, and dots depict outliers. 
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Table 1. Characteristics of the study population, stratified by sex. 
 Men Women 
Prevalence, % 44 56 
Age, years 57 (51-62) 56 (50-61) 
Ethnicity, % Caucasian 95.1 94.7 
Education, % high 48.1 44.4 
Income*, % 
- Less than €500 up to €1500 
- €1500 up to €2500 
- €2500 or more 
- Unknown  
 
11.2 
38.9 
39.7 
10.2 
 
52.9 
27.0 
5.4 
14.7 
BMI, kg/m2 26.4 (24.4-28.7) 25.1 (22.4-28.0) 
Fulfilling ACR criteria for hand OA [10], % 6.3 18.0 
Primary hand OA†, % 5.5 16.3 
“Pre-hand OA”‡, % 3.3 7.9 
Self-reported inflammatory rheumatic disease, % 
- Rheumatoid arthritis 
- SLE 
- Psoriatic arthritis 
- Gout 
- Ankylosing spondylitis 
4.6 
1.2 
0.1 
0.1 
2.8 
0.4 
3.9 
2.4 
0.1 
0.2 
1.0 
0.2 
Self-reported fibromyalgia, % 0.3 3.0 
AUSCAN total score (range 0-60) 0 (0-1) 2 (0-8) 
AUSCAN pain subscale (range 0-20) 0 (0-0) 0 (0-2) 
AUSCAN stiffness subscale (range 0-4) 0 (0-0) 0 (0-1) 
AUSCAN function subscale (range 0-36) 0 (0-0) 1 (0-5) 
Results are based on weighted analyses of the study population (n=6643). Medians (interquartile range) are 
reported unless otherwise specified. 
*Net monthly personal income. †Defined as fulfilment of the ACR criteria for hand OA, without a concurrent 
inflammatory rheumatic disease (RA, SLE, gout, PsA, or AS). ‡Defined as the presence of hand pain in 
combination with at least two bony swellings or deformities in the DIPs, PIPs, or first CMC joints, and not being 
classified as having primary hand OA or reporting a concurrent inflammatory rheumatic disease. 
ACR, American College of Rheumatology; AS, ankylosing spondylitis; AUSCAN, Australian/Canadian Hand 
Osteoarthritis Index; BMI, body mass index; CMC, carpometacarpal; DIP, distal interphalangeal; OA, 
osteoarthritis; PIP, proximal interphalangeal; PsA, psoriatic arthritis; RA, rheumatoid arthritis; SLE, systemic 
lupus erythematosus. 
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Table 2. Factors associated with AUSCAN total scores, stratified by sex. 
 Univariable OLR (OR (95% CI)) Multivariable OLR (OR (95% CI)) 
 Men Women Men Women 
Age (years) 1.03 (1.01 to 1.05) 1.07 (1.05 to 1.08) 1.02 (1.00 to 1.04) 1.04 (1.02 to 1.06) 
Education (high vs other) 0.75 (0.61 to 0.93) 0.76 (0.63 to 0.91) 0.79 (0.62 to 1.00) 0.95 (0.77 to 1.17) 
BMI (kg/m2) 1.03 (1.00 to 1.05) 1.04 (1.02 to 1.05) 0.99 (0.96 to 1.02) 1.01 (1.00 to 1.03) 
Primary hand OA 14.11 (9.42 to 21.14) 9.55 (7.09 to 12.87) 18.37 (11.94 to 28.27) 12.37 (8.92 to 17.15) 
“Pre-hand OA” 9.81 (6.10 to 15.75) 5.51 (3.72 to 8.17) 15.39 (9.24 to 25.62) 9.64 (6.28 to 14.81) 
Inflammatory rheumatic 
disease* 
2.44 (1.55 to 3.85) 4.78 (2.95 to 7.74) 3.15 (1.85 to 5.37) 8.78 (5.22 to 14.78) 
Fibromyalgia 246.76 (29.84 to 
2040.97) 
20.13 (9.73 to 41.64) 228.00 (23.64 to 
2198.82) 
13.67 (6.23 to 30.00) 
Results are based on weighted analyses of the study population. 
*Including RA, SLE, gout, PsA or AS. 
AS, ankylosing spondylitis; AUSCAN, Australian/Canadian Hand Osteoarthritis Index; BMI, body mass index; CI, 
confidence interval; OA, osteoarthritis; OLR, ordered logistic regression; OR, odds ratio; PsA, psoriatic arthritis; 
RA, rheumatoid arthritis; SLE, systemic lupus erythematosus. 
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Table 3. Calculated age- and sex-specific percentiles for AUSCAN total, AUSCAN pain and AUSCAN 
function. 
  Percentiles 
  Men Women 
Measure Age 75th 90th 95th 97.5th 99th 75th 90th 95th 97.5th 99th 
AUSCAN total 45 0.9 3.4 5.0 11.0 17.9 1.9 6.1 15.2 23.4 39.3 
 50 1.0 3.9 9.6 15.9 22.3 5.6 15.1 23.1 32.3 39.8 
 55 1.1 4.6 11.1 18.1 25.6 8.5 20.4 27.8 35.3 40.0 
 60 1.5 5.7 11.8 19.4 28.4 10.9 24.2 31.0 36.8 40.1 
 65 2.1 7.0 12.3 20.3 30.9 13.0 27.1 33.6 37.7 40.1 
AUSCAN pain 45 0 1.7 5.0 5.0 7.5 0 2.0 7.2 8.6 12.2 
 50 0 1.8 5.0 7.4 11.8 1.3 6.0 9.6 11.0 13.0 
 55 0 2.2 5.0 7.8 11.8 2.5 7.7 10.4 11.8 13.8 
 60 0 2.9 5.0 8.0 10.7 3.8 8.8 10.8 12.2 14.7 
 65 0 4.0 5.0 8.0 9.3 5.0 9.5 11.1 12.4 15.5 
AUSCAN function 45 0 1.8 3.0 5.4 10.2 1.3 3.5 7.0 14.0 22.8 
 50 0.1 2.0 5.0 7.6 13.5 3.8 9.0 14.0 19.3 24.4 
 55 0.2 2.3 5.7 9.3 16.0 5.3 12.3 17.1 21.6 25.0 
 60 0.6 3.0 6.0 10.7 18.1 6.4 14.6 18.9 23.0 25.3 
 65 1.1 4.0 6.2 12.0 20.0 7.2 16.4 20.2 24.0 25.4 
Results are based on weighted analyses of the study population. 
AUSCAN, Australian/Canadian Hand Osteoarthritis Index. 
  
20 
 
Supplementary files 
Online supplementary text 1. 
Regression function of the reference curves  
The function of the regression line of each percentile curve is the following: 
𝒀𝑸 =  𝜷𝟎
𝑸 + 𝜷𝟏
𝑸  ∙ 𝑿𝟏 
with YQ AUSCAN at Qth percentile 
 β0Q Intercept at Qth percentile 
 β1Q Regression coefficient of X1 at Qth percentile 
 X1 Age variable, which is calculated as follows: 
 
𝐗𝟏 = (
𝒂𝒈𝒆 − 𝟒𝟎
𝟏𝟎
)
𝑭𝑷
− 𝒔𝒇 
 
with FP Fractional polynomial power, taken from a predefined set: S = {-2, 
-1, -0.5, 0, 0.5, 1, 2, 3}, where X0 denotes ln(X) 
   sf Scaling factor, which is calculated as follows: 
 
     𝒔𝒇 = (
𝒀
𝒊
)
𝑭𝑷
 
     
with 𝒀 Mean AUSCAN 
 i Estimated by STATA depending on possible values of X and Y 
 FP Fractional polynomial power  
   
If the independent variable in regression analyses with fractional polynomials is too large or too 
small, the reported results of the analysis may be difficult to interpret. That is why age was scaled 
before adding it to the regression equation (by subtracting 40 and subsequently dividing by 10) in 
order to ensure its magnitude was neither too large nor too small. 
 
The value of i is calculated automatically by the statistical package for scaling purposes of the 
regression coefficient. The scaling factor sf is provided in the output of the regression analysis. 
 
Example: What is the AUSCAN total in a 60 year old man at the 97.5th percentile? 
 
β0Q = 18.44 
β1Q = -11.90 
FP = -0.5 
sf = 0.79 
 
𝒀𝑸 =  𝜷𝟎
𝑸 + 𝜷𝟏
𝑸  ∙ ((
𝒂𝒈𝒆−𝟒𝟎
𝟏𝟎
)
𝑭𝑷
− 𝒔𝒇)  
𝒀𝟕𝟓𝒕𝒉 =  18.44 + −11.90 ∙ ((
60−40
10
)
−0.5
− 0.79)  
𝒀𝟕𝟓𝒕𝒉 ≈  19.4  
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Supplementary table S1. Intercepts, regression coefficients with 95% confidence interval, fractional 
polynomial powers and scaling factor for each of the quantile regression curves. 
  Men Women 
 Percentile β0 β1 (95% CI) FP sf β0 β1 (95% CI) FP sf 
AUSCAN total 75th 1.20 0.08 (0.03 to 0.13) 3 4.11 8.79 12.65 (9.63 to 15.67) 0.5 1.25 
 90th  4.81 0.60 (0.02 to 1.17) 2 2.56 20.87 13.07 (9.03 to 17.11) 0 0.44 
 95th  11.30 -4.58 (-9.02 to -0.14) -1 0.62 28.15 11.43 (6.12 to 16.74) 0 0.44 
 97.5th 18.44 -11.90 (-28.01 to 4.20) -0.5 0.79 35.53 -8.93 (-18.23 to 0.38) -1 0.64 
 99th  26.30 14.88 (-7.40 to 37.16) 0.5 1.27 40.01 -0.55 (-13.63 to 12.54) -1 0.64 
AUSCAN pain 75th * * * * 2.65 2.50 (1.83 to 3.17) 1 1.56 
 90th  2.28 0.15 (0.02 to 0.27) 3 4.11 7.90 -9.62 (-13.66 to -5.58) -0.5 0.80 
 95th  5.00 0.00 (-1.75 to 1.75) -1 0.62 10.49 -2.45 (-4.42 to -0.49) -1 0.64 
 97.5th 7.86 -0.79 (-1.74 to 0.15) -2 0.39 11.87 -2.38 (-4.40 to -0.36) -1 0.64 
 99th 11.65 2.34 (-3.39 to 8.07) 
-5.50 (-12.61 to 1.60)† 
0 
0† 
0.47 
0.22† 
13.93 1.67 (-0.01 to 3.35) 1 1.56 
AUSCAN function 75th 0.29 0.07 (0.03 to 0.12) 3 4.11 5.43 3.64 (3.00 to 4.28) 0 0.44 
 90th  2.39 0.14 (0.03 to 0.25) 3 4.11 12.55 8.00 (5.66 to 10.33) 0 0.44 
 95th  5.75 -2.00 (-3.53 to -0.47) -1 0.62 17.37 -16.94 (-24.30 to -9.58) -0.5 0.80 
 97.5th 9.62 7.54 (-0.50 to 15.58) 0.5 1.27 21.85 -12.79 (-25.54 to -0.04) -0.5 0.80 
 99th  16.48 11.16 (-1.15 to 23.47) 0.5 1.27 25.04 -1.64 (-8.11 to 4.84) -1 0.64 
*Values could not be estimated because the AUSCAN pain values in this percentile are not higher than zero. 
†The 99th percentile curve of AUSCAN pain for men was estimated with a second degree fractional polynomial 
function, which means that a second regression coefficient (β1aQ) with a corresponding polynomial (FPb) was 
added to the regression function to improve model fit (𝑌𝑄 =  𝛽0
𝑄 + 𝛽1𝑎
𝑄  ∙ 𝑋1𝑎 + 𝛽1𝑏
𝑄  ∙ 𝑋1𝑏). The age variable 
corresponding to the second regression coefficient is calculated as follows:X1𝑏 = ((
𝑎𝑔𝑒−40
10
)
𝐹𝑃𝑏
∙ ln (
𝑎𝑔𝑒−40
10
)) −
 𝑠𝑓1𝑏. 
AUSCAN, Australian/Canadian Hand Osteoarthritis Index; CI, confidence interval; FP, fractional polynomial 
power; sf, scaling factor; β0, intercept; β1, regression coefficient. 
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Figure 1 (colour – online version) 
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Figure 1 (grey scale – printed version) 
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Figure 2 (colour – online version) 
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Figure 2 (grey scale – printed version) 
 
